Dr. Maha Radhakrishnan, former Biogen CMO, joined Sofinnova Investments this week as Executive Partner

blonca9
Aug 9, 2024
1 min read

She describes why she decided to move to the investment side and Sofinnova, what areas of science interest her today, and some thoughts on the Alzheimer's space given her experience at Biogen.

Recent Posts

See All

RBC Global Healthcare Conference: Desk Strategist Chris McCarthy shares how institutional investors have been affected by policy and macro factors, and how they have been positioning around catalysts

RBC Global Healthcare Conference: Senior Biotech Analyst Luca Issi shares his thoughts on the current state of gene and cell therapy

RBC Global Healthcare Conference: RBC's Brian Abrahams shares his take on biotech and offers advice for companies on how to navigate these times of change

Dr. Maha Radhakrishnan, former Biogen CMO, joined Sofinnova Investments this week as Executive Partner

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight